文献速递湿疹皮炎与荨麻疹银屑病与炎症性皮肤病自身免疫性与大疱性皮肤病

成人脂溢性皮炎与上皮屏障疾病的关联

Epithelial Barrier Diseases Among Adult Patients With Seborrheic Dermatitis.
PubMed 文献 · JAMA Dermatol · 2026-01-01

调整模型显示,脂溢性皮炎与特应性皮炎、斑秃、接触性皮炎、银屑病、酒渣鼻等多种上皮屏障疾病呈正相关,支持上皮屏障理论作为共享驱动因素。

要点

  • 脂溢性皮炎患者中多种上皮屏障疾病(如特应性皮炎、银屑病、酒渣鼻)的患病 odds 显著升高。
  • 脂溢性皮炎与慢性阻塞性肺疾病和肺动脉高压呈负相关。
  • 提示脂溢性皮炎可能是上皮屏障功能障碍的系统性标志,需关注共病筛查。

核心结论

  • 脂溢性皮炎与多种上皮屏障疾病呈正相关,支持上皮屏障理论作为共享驱动因素。

研究设计与样本

  • 回顾性队列研究,使用美国大型行政索赔数据库,纳入2016年1月1日至2022年6月30日期间≥18岁、连续入组≥1年、至少2次不同日期就诊的患者。

主要发现

  • 脂溢性皮炎与特应性皮炎(OR 3.21;95% CI 3.18-3.24)、斑秃(OR 4.02;95% CI 3.93-4.11)、接触性皮炎(OR 2.25;95% CI 2.23-2.26)、银屑病(OR 3.26;95% CI 3.23-3.29)、酒渣鼻(OR 4.52;95% CI 4.49-4.56)呈正相关。
  • 脂溢性皮炎与化脓性汗腺炎(OR 1.63;95% CI 1.58-1.68)、慢性自发性荨麻疹(OR 1.35;95% CI 1.33-1.37)、寻常型天疱疮(OR 1.48;95% CI 1.31-1.69)、大疱性类天疱疮(OR 1.60;95% CI 1.51-1.70)呈正相关。
  • 脂溢性皮炎与鼻窦炎(OR 1.24;95% CI 1.24-1.25)、乳糜泻(OR 1.36;95% CI 1.32-1.39)、肠易激综合征(OR 1.32;95% CI 1.31-1.33)、眼部过敏(OR 1.39;95% CI 1.37-1.41)、干眼(OR 1.48;95% CI 1.48-1.49)呈正相关。
  • 脂溢性皮炎与慢性阻塞性肺疾病(OR 0.72;95% CI 0.71-0.72)和肺动脉高压(OR 0.70;95% CI 0.69-0.71)呈负相关。

临床怎么用

  • 对脂溢性皮炎患者应警惕合并其他上皮屏障疾病(如特应性皮炎、银屑病、酒渣鼻、斑秃等),必要时进行多学科评估。

局限性

  • 回顾性队列设计基于行政索赔数据库,可能存在编码偏倚和混杂因素。
  • 缺乏上皮屏障功能的直接测量指标,关联不能推断因果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The epithelial barrier theory (EBT) proposes that epithelial barrier disruption is implicated in the development of skin, respiratory, gastrointestinal, and ocular diseases (epithelial barrier diseases, or EBDs). There is a need to better understand the relationship between seborrheic dermatitis and EBDs, and we hypothesize that seborrheic dermatitis, characterized by epithelial barrier dysfunction, is associated with increased frequency of other EBDs. OBJECTIVE: To explore the association between seborrheic dermatitis and EBDs. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used a large US administrative claims database, which included data collected from multiple health care centers and patient care settings across the US from January 1, 2016, through June 30, 2022. This study consisted of patients aged 18 years and older at enrollment, with at least 1 year of continuous enrollment, and with a minimum of 2 visits on unique days to a medical professional. The mean (SD) patient follow-up time was 3.46 (1.80) years with a total follow-up of more than 70 million person-years. Individuals with missing data for demographic covariates, including age, sex, and division (ie, billing region), were excluded. Data were analyzed from January to September 2025. EXPOSURES: Diagnosis of seborrheic dermatitis at any point during the observation period. MAIN OUTCOMES AND MEASURES: Diagnosis of an EBD at any point during the observation period. RESULTS: Of 20 274 189 patients, 733 776 (3.62%) had seborrheic dermatitis (median [IQR] age, 62.63 [41.53-70.55] years; 54.7% female). Using adjusted models, seborrheic dermatitis was positively associated with atopic dermatitis (odds ratio [OR], 3.21; 95% CI, 3.18-3.24), alopecia areata (OR, 4.02; 95% CI, 3.93-4.11), contact dermatitis (OR, 2.25; 95% CI, 2.23-2.26), psoriasis (OR, 3.26; 95% CI, 3.23-3.29), rosacea (OR, 4.52; 95% CI, 4.49-4.56), hidradenitis suppurativa (OR, 1.63; 95% CI, 1.58-1.68), chronic spontaneous urticaria (OR, 1.35; 95% CI, 1.33-1.37), pemphigus vulgaris (OR, 1.48; 95% CI, 1.31-1.69), bullous pemphigoid (OR, 1.60; 95% CI, 1.51-1.70), rhinosinusitis (OR, 1.24; 95% CI, 1.24-1.25), celiac disease (OR, 1.36; 95% CI, 1.32-1.39), irritable bowel syndrome (OR, 1.32; 95% CI, 1.31-1.33), ocular allergy (OR, 1.39; 95% CI, 1.37-1.41), and dry eye (OR, 1.48; 95% CI, 1.48-1.49) and was negatively associated with chronic obstructive pulmonary disease (OR, 0.72; 95% CI, 0.71-0.72) and pulmonary hypertension (OR, 0.70; 95% CI, 0.69-0.71). CONCLUSIONS AND RELEVANCE: These findings support the EBT as a shared driver in the pathogenesis of seborrheic dermatitis and other diverse EBDs and encourage further investigation into the underlying mechanisms of disease pathogenesis.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Meng S, Berna R, Hoffstad O, et al. Epithelial Barrier Diseases Among Adult Patients With Seborrheic Dermatitis. JAMA Dermatol. 2026. PMID: 41191376. doi:10.1001/jamadermatol.2025.4313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。